Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 10Peritoneal Neoplasms 9Stomach Neoplasms 5Colorectal Neoplasms 5Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Appendiceal Neoplasms 3Recurrence 2Wilms Tumor 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Pseudomyxoma Peritonei 1Malignant Neoplasm of Colorectum 1Krukenberg Tumor 1Invasive Bladder Cancer 1Flushing 1Desmoplastic Small Round Cell Tumor 1Advanced Ovarian Cancer 1Acute Kidney Injury 1

Interventions

tremelimumab 1durvalumab 1Sodium Chloride 1Radiotherapy 1Lidocaine 1Hyperthermic Intraperitoneal Chemotherapy 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Invasive Bladder Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03514888 2023-08-28

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Weill Medical College of Cornell University

Phase NA Completed
7 enrolled
Genitourinary

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡